JPMorgan Chase & Co’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4K | Hold |
13,432
| – | – | ﹤0.01% | 5243 |
|
|
2025
Q1 | $18.3K | Hold |
13,432
| – | – | ﹤0.01% | 5308 |
|
|
2024
Q4 | $17.9K | Sell |
13,432
-3,419
| -20% | -$4.55K | ﹤0.01% | 5250 |
|
|
2024
Q3 | $19.5K | Sell |
16,851
-1,073
| -6% | -$1.25K | ﹤0.01% | 5208 |
|
|
2024
Q2 | $23.8K | Sell |
17,924
-18,752
| -51% | -$24.9K | ﹤0.01% | 5107 |
|
|
2024
Q1 | $72.3K | Sell |
36,676
-281,338
| -88% | -$554K | ﹤0.01% | 4846 |
|
|
2023
Q4 | $448K | Buy |
318,014
+178,135
| +127% | +$251K | ﹤0.01% | 3972 |
|
|
2023
Q3 | $180K | Buy |
139,879
+49,574
| +55% | +$64K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $155K | Buy |
90,305
+83,226
| +1,176% | +$143K | ﹤0.01% | 4419 |
|
|
2023
Q1 | $13K | Sell |
7,079
-13,361
| -65% | -$24.5K | ﹤0.01% | 5221 |
|
|
2022
Q4 | $55K | Buy |
20,440
+8,647
| +73% | +$23.3K | ﹤0.01% | 4709 |
|
|
2022
Q3 | $39K | Buy |
11,793
+3,362
| +40% | +$11.1K | ﹤0.01% | 4769 |
|
|
2022
Q2 | $31K | Sell |
8,431
-11,057
| -57% | -$40.7K | ﹤0.01% | 4964 |
|
|
2022
Q1 | $99K | Buy |
19,488
+5,357
| +38% | +$27.2K | ﹤0.01% | 4750 |
|
|
2021
Q4 | $108K | Buy |
+14,131
| New | +$108K | ﹤0.01% | 4789 |
|